Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription (Q41096837)

26 September 2017

title

Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription (English)

1 reference

26 September 2017

1 reference

Rolfe FG

1

1 reference

26 September 2017

Valentine JE

series ordinal

2

1 reference

26 September 2017

Sewell WA

series ordinal

3

1 reference

26 September 2017

publication date

1 August 1997

1 reference

American Journal of Respiratory Cell and Molecular Biology

26 September 2017

published in

1 reference

26 September 2017

volume

17

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

243-250

1 reference

The eosinophilic leukocyte: structure and function

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Eosinophilic Inflammation in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

21 January 2018

Regulated mRNA stability

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5'-CGAAAATTTCC-3') of the human interleukin-4 gene: relationship to NF-kappa B and NF-AT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Identification of a putative regulator of early T cell activation genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

FK506 and cyclosporin, molecular probes for studying intracellular signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. Involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.17.2.2819

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.17.2.2819

1 reference

26 September 2017

1 reference